The Minnesota Cancer Clinical Trials Network (MNCCTN) aims to improve cancer outcomes for all Minnesotans through greater access to cancer clinical trials in prevention and treatment.
The impact of cancer in Minnesota
Nearly half of all Minnesotans will be diagnosed with a potentially life-threatening cancer during their lifetimes
One out of four Minnesotans die of cancer
To impact these grim statistics, healthcare providers across the state need access to cutting-edge cancer research, including cancer clinical trials.
January is Cervical Cancer Awareness Month. Every year, more than 13,000 women are diagnosed with cervical cancer in the United States. However, cervical cancer is preventable with vaccinations and regular screening.
Since its launch in 2018, the Minnesota Cancer Clinical Trials Network (MNCCTN), has enrolled more than 350 Minnesotans on prevention, symptom management, and cancer treatment protocols near their homes in Greater Minnesota.